Published in Biochem Pharmacol on June 15, 1991
The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol (2007) 3.68
Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole. Toxicol Sci (2011) 0.77
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol (1995) 7.12
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03
The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev (1996) 5.71
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem (1998) 2.37
Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem (1996) 2.25
Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem (1998) 1.76
Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A (1999) 1.73
Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle. Res Vet Sci (1999) 1.30
Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett (2000) 1.14
Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem J (2001) 1.10
Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J Vet Pharmacol Ther (1997) 1.04
Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway. Toxicol Lett (1998) 1.03
Licking behaviour and environmental contamination arising from pour-on ivermectin for cattle. Int J Parasitol (2001) 1.01
Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology (2004) 0.99
Milk kinetics of moxidectin and doramectin in goats. Res Vet Sci (2001) 0.99
Influence of acoustic stress by noise on gastrointestinal motility in dogs. Dig Dis Sci (1987) 0.98
Evidence for the ligand-independent activation of the AH receptor. Biochem Biophys Res Commun (1995) 0.96
Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection. J Chromatogr B Biomed Appl (1995) 0.95
Interspecies variations of corticosteroid-binding globulin parameters. Domest Anim Endocrinol (1996) 0.95
Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. Eur J Biochem (2001) 0.94
Eprinomectin in dairy goats: dose influence on plasma levels and excretion in milk. Parasitol Res (2001) 0.93
Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8'-carotenal, with no affinity for the TCDD binding site. Biochem Pharmacol (1997) 0.93
In vitro transformation of ochratoxin A by animal microbioal floras. Ann Rech Vet (1976) 0.92
Identification of dioxin-responsive elements (DREs) in the 5' regions of putative dioxin-inducible genes. Chem Biol Interact (1996) 0.92
Vagally mediated inhibition of acoustic stress-induced cortisol release by orally administered kappa-opioid substances in dogs. Endocrinology (1989) 0.92
Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Vet Parasitol (2000) 0.91
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. J Vet Pharmacol Ther (1994) 0.91
Fasciola hepatica: influence of gender and liver biotransformations on flukicide treatment efficacy of rats infested and cured with either clorsulon/ivermectin or triclabendazole. Exp Parasitol (2000) 0.91
The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food Cosmet Toxicol (1981) 0.91
Persistence of ivermectin in plasma and faeces following administration of a sustained-release bolus to cattle. Res Vet Sci (1999) 0.90
Moxidectin in cattle: correlation between plasma and target tissues disposition. J Vet Pharmacol Ther (1999) 0.90
Subclinical doses of T-2 toxin impair acquired immune response and liver cytochrome P450 in pigs. Toxicology (2008) 0.90
P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Parasitology (2009) 0.90
Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol (2003) 0.89
Activity of eprinomectin in goats against experimental infections with Haemonchus contortus, Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet Rec (1999) 0.89
The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep. Vet Res (1998) 0.89
PPARalpha transcriptionally induces AhR expression in Caco-2, but represses AhR pro-inflammatory effects. Biochem Biophys Res Commun (2007) 0.88
Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2. Pharmacogenetics (1996) 0.88
Pharmacokinetics of ivermectin in zebu Gobra (Bos indicus). Vet Parasitol (2004) 0.86
Xenobiotic receptor knockout mice. Toxicol Lett (1995) 0.86
Kinetic and insecticidal properties of ivermectin residues in the milk of dairy cows. J Vet Pharmacol Ther (1988) 0.86
In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice. J Lipid Res (1999) 0.86
Pharmacokinetics of selamectin in dogs after topical application. Vet Res Commun (2004) 0.85
The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration. Drug Metab Dispos (1980) 0.85
Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland. Am J Vet Res (1984) 0.84
Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration. J Vet Pharmacol Ther (2007) 0.84
Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochem Biophys Res Commun (1994) 0.84
The pharmacokinetics of xylazine hydrochloride: an interspecific study. J Vet Pharmacol Ther (1981) 0.84
Efficacy of eprinomectin pour-on against gastrointestinal nematodes and the nasal bot fly (Oestrus ovis) in sheep. Vet Rec (2004) 0.84
Eprinomectin in goat: assessment of subcutaneous administration. Parasitol Res (2002) 0.84
Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes. Biochem Biophys Res Commun (1997) 0.83
Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs. Curr Drug Metab (2009) 0.83
Modulation of prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch Biochem Biophys (1998) 0.83
Eprinomectin in dairy zebu Gobra cattle (Bos indicus): plasma kinetics and excretion in milk. Parasitol Res (2006) 0.82
Pharmacokinetics of moxidectin and doramectin in goats. Res Vet Sci (1999) 0.82
Purification and characterization of a glutathione S-transferase Omega in pig: evidence for two distinct organ-specific transcripts. Biochem J (2001) 0.82
Comparative bioavailability of levamisole in non lactating ewes and goats. Ann Rech Vet (1981) 0.82
Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes. Int J Immunopharmacol (1999) 0.82
Ivermectin in goat plasma and milk after subcutaneous injection. Vet Res (1993) 0.81
The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep. J Vet Pharmacol Ther (2003) 0.81
Determination of eprinomectin in plasma by high-performance liquid chromatography with automated solid phase extraction and fluorescence detection. Analyst (1998) 0.81
The negative effects of the residues of ivermectin in cattle dung using a sustained-release bolus on Aphodius constans (Duft.) (Coleoptera: Aphodiidae). Vet Res (2001) 0.81
In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species. Vet Res Commun (2001) 0.81
Comparison of hepatic and extrahepatic drug-metabolizing enzyme activities in rats given single or multiple challenge infections with Fasciola hepatica. Int J Parasitol (1995) 0.81
Individual and combined effects of low oral doses of deoxynivalenol and nivalenol in mice. Cell Mol Biol (Noisy-le-grand) (2005) 0.81
Comparison of the pharmacokinetics of moxidectin (Equest) and ivermectin (Eqvalan) in horses. J Vet Pharmacol Ther (1999) 0.81
Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta-hydroxylation. Biochem Pharmacol (1998) 0.80
Hydrocortisone secretion: production rate and pulse characterization by numerical deconvolution. Am J Physiol (1988) 0.80
Simultaneous determination of corticosterone, hydrocortisone, and dexamethasone in dog plasma using high performance liquid chromatography. J Pharm Sci (1982) 0.80
Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil. Parasitol Res (1999) 0.79
Determination of aditoprim and its oxidative metabolites in plasma and microsomal incubation mixtures by high-performance liquid chromatography. J Chromatogr (1993) 0.79
Faecal excretion profile of moxidectin and ivermectin after oral administration in horses. Vet J (2001) 0.79
Naturally occurring scrapie is associated with a lower CBG binding capacity in ewes. J Endocrinol (2000) 0.79
A nonlabeled method to evaluate cortisol production rate by modeling plasma CBG-free cortisol disposition. Am J Physiol Endocrinol Metab (2001) 0.79
Effect of various doses of deoxynivalenol on liver xenobiotic metabolizing enzymes in mice. Food Chem Toxicol (2005) 0.79